Industry News
Improved Tool To Remove Stroke-Causing Blood Clots
Aug 28, 2012
Stroke is the fourth leading cause of death and a common cause of long-term disability in the United States, but doctors have very few proven treatment methods. Now a new device that mechanically removes stroke-causing clots from the brain is being hailed as a game-changer... Read More
Anti-Clotting Drugs Prasugrel And Clopidogrel Yield Similar Results
Aug 28, 2012
The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs - prasugrel and clopidogrel - in preventing the first occurrence of death, heart attack or stroke, according to Duke University Medical Center cardiologists... Read More
Anti-Clotting Drugs Prasugrel And Clopidogrel Yield Similar Results
Aug 28, 2012
The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs - prasugrel and clopidogrel - in preventing the first occurrence of death, heart attack or stroke, according to Duke University Medical Center cardiologists... Read More
Breast Cancer Recurrence Higher Among Overweight Women
Aug 27, 2012
Obese and overweight women are more likely to experience breast cancer recurrence compared to women of normal weight, regardless of the type of cancer treatment they received, researchers reported in the journal Cancer... Read More
Trastuzumab Emtansine (T-DM1) Significantly Improves Breast Cancer Survival
Aug 27, 2012
The investigational drug, Trastuzumab Emtansine (T-DM1), improves survival of patients with HER2-Positive metastatic breast cancer "significantly", Genentech Inc. announced today as it published highlights of its Phase III EMILIA study results. T-DM1 was compared to lapatinib and Xeloda (capecitabine) combination therapy... Read More
Since The Introduction Of PSA Testing, Prostate Cancer Survival Rates Have Improved
Aug 27, 2012
The routine use of prostate specific antigen (PSA) testing for screening and monitoring prostate cancer has led to early and more sensitive detection of the disease... Read More
Racial Disparities In Prostate Cancer Care
Aug 27, 2012
A study led by investigators from Vanderbilt-Ingram Cancer Center (VICC), Nashville, Tenn., finds that black men with prostate cancer receive lower quality surgical care than white men. The racial differences persist even when controlling for factors such as the year of surgery, age, comorbidities and insurance status. Daniel Barocas, M.D... Read More
Racial Disparities In Prostate Cancer Care
Aug 27, 2012
A study led by investigators from Vanderbilt-Ingram Cancer Center (VICC), Nashville, Tenn., finds that black men with prostate cancer receive lower quality surgical care than white men. The racial differences persist even when controlling for factors such as the year of surgery, age, comorbidities and insurance status. Daniel Barocas, M.D... Read More
Human Melanoma Stem Cells Identified
Aug 27, 2012
Cancer stem cells are defined by three abilities: differentiation, self-renewal and their ability to seed a tumor. These stem cells resist chemotherapy and many researchers posit their role in relapse... Read More
Human Melanoma Stem Cells Identified
Aug 27, 2012
Cancer stem cells are defined by three abilities: differentiation, self-renewal and their ability to seed a tumor. These stem cells resist chemotherapy and many researchers posit their role in relapse... Read More
Previous Page Next Page